Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and nine months ended September 30, 2013. Highlights of the third quarter of 2013 and recent weeks include:
•Advanced wound care (AWC) product sales of $9.1 million, up 33% over the prior-year third quarter
Help employers find you! Check out all the jobs and post your resume.
